Device Trial Radar · NCT02394912
Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF System
Last checked: Nov 19, 2026Latest source record: Jul 30, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
21
Actual
Start
Jun 2015
Primary completion
Nov 9, 2016
Study completion Nov 9, 2016
Sponsor
- Lead sponsor
- Volcano CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 20, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and effectiveness of the LUMIFI with Crux VCF System for deployment of the Crux VCF. The study will compare the method of Crux VCF deployment using the LUMIFI with Crux VCF System (IVUS guidance) with the historical results of the Crux VCF System (fluoroscopic guidance). The study will include enrollment into a roll in phase consisting of 2 study subjects per site prior to enrollment into the primary treatment phase for primary analyses. The purpose of the roll in phase is to assure compliance with site training on the use of the investigational device and protocol workflow.
Conditions
- Pulmonary Embolism
- Deep Vein Thrombosis
Interventions
vena cava filter implantation (LUMIFI with Crux VCF System)Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Technical Success RateTime frame: Day 1
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Surgical Care Associates
Louisville, Kentucky
Vascular Access Solutions
Orangeburg, South Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.